Header Logo

Connection

SUSAN BLANEY to Interferon-alpha

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Interferon-alpha.
SUSAN BLANEY
Connection Strength
0.028
Interferon-alpha
  1. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer. J Clin Oncol. 1997 Nov; 15(11):3330-7.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.